Unichem Laboratories Ltd.
Snapshot View

View in App

Prices View details >>

299.40 +28.90 ▲10.7%

27 January 2023, 04:01:00 PM
Volume: 26,566

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.unichemlabs.com
Market Cap 1,997.41 Cr.
Enterprise Value(EV) 1,858.91 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -5.21 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 33.61 Trailing Twelve Months Ending 2022-09
Book Value / Share 357.03 Trailing Twelve Months Ending 2022-09
Price to Book Value 0.79 Calculated using Price: 283.70
Dividend Yield 1.41 Period Ending 2022-03
No. of Shares Subscribed 7.04 Cr. 70,405,751 Shares
FaceValue 2
Company Profile
Unichem Laboratories, incorporated in 1962, is engaged in manufacturing formulations, pharmaceuticals and active pharmaceutical ingredients (APIs). The company was promoted by the late Amrut Mody, a pioneer in the Indian pharmaceuticals business.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+10.68%
1 Week
+5.29%
1 Month
+2.76%
3 Month
-24.22%
6 Month
+6.47%
1 Year
+9.57%
2 Year
+3.58%
5 Year
-17.59%
10 Year
+58.58%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 16.62 8.95 11.92 10.77 136.04 -0.90 -2.37 1.37 1.32
Return on Capital Employed (%) 21.84 9.29 14.97 13.42 162.77 -1.77 -1.49 2.12 1.04
Return on Assets (%) 11.56 6.55 8.82 7.68 108.06 -0.75 -1.94 1.11 1.06

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 817 868 954 1,064 2,680 2,620 2,531 2,557 2,618 2,545
Non Curr. Liab. 98 74 76 64 46 10 44 49 144 127
Curr. Liab. 230 212 275 393 464 503 567 506 552 487
Minority Int.
Equity & Liab. 1,145 1,153 1,305 1,521 3,190 3,133 3,142 3,112 3,314 3,159
Non Curr. Assets 564 589 673 772 854 1,094 1,455 1,734 1,666 1,619
Curr. Assets 581 564 632 748 2,336 2,039 1,686 1,377 1,648 1,540
Misc. Exp. not W/O
Total Assets 1,145 1,153 1,305 1,521 3,190 3,133 3,142 3,112 3,314 3,159

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 1,133 1,202 1,333 1,540 1,380 1,188 1,104 1,235 1,270 1,320
Other Income 42 21 19 6 3,278 98 91 50 48 46
Total Income 1,176 1,223 1,352 1,546 4,658 1,287 1,195 1,285 1,317 1,366
Total Expenditure -956 -1,101 -1,169 -1,358 -1,358 -1,269 -1,155 -1,144 -1,197 -1,271
PBIDT 220 122 183 188 3,300 17 40 141 120 95
Interest -3 -3 -3 -3 -8 -8 -8 -5 -6 -11
Depreciation -46 -41 -39 -44 -51 -67 -82 -84 -91 -100
Taxation -43 -2 -29 -33 -696 34 -12 -17 11 -15
Exceptional Items -4 -5
PAT 128 75 108 108 2,545 -24 -61 35 34 -36
Minority Interest
Share Associate 0 0 0 0 0 1 0 -1 -1
Other Related Items
Consolidated Net Profit 169 75 108 109 2,545 -24 -60 34 33 -37
Adjusted EPS 14 8 12 12 362 -3 -9 5 5 -5

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 171 87 78 112 68 -112 -328 20 33 -260
Cash Fr. Inv. -118 36 -52 -85 -128 1,648 -286 -36 -74 100
Cash Fr. Finan. -51 -95 -51 -33 59 -881 -2 -62 -121 191
Net Change 1 28 -25 -7 0 655 -616 -78 -162 32
Cash & Cash Eqvt 25 52 27 20 11 666 197 232 77 109

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 50.93 50.93 50.93 50.93 50.93 50.93 50.93 50.93 50.93
Public 49.07 49.07 49.07 49.07 49.07 49.07 49.07 49.07 49.07
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 13 Jan 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Advertisement Published in Newspapers regarding a Notice for the transfer of Equity Shares and Unclaimed Dividends to the Investor Education and Protection Fund (IEPF) Account.
Tue, 10 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Compliance Certificate under regulation 74[5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2022.
Fri, 30 Dec 2022
Closure of Trading Window
Closure of trading window

Technical Scans View Details >>

Wed, 25 Jan 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Closing Below Previous Low Closing Below Previous Low
Close Below Last Week Low Close Below Last Week Low

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,518.84 1,040.75 +0.1%
Divi's Laboratories Ltd. 88,552.35 3,385.55 +1.5%
Cipla Ltd. 83,862.25 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 69,879.98 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 60,777.77 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,497.96 1,537.85 -1.3%
Abbott India Ltd. 45,101.64 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.79 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 29.71 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-09 32.68 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 22.47 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.39 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 65.87 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.15 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.33 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-09 3.83 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.36 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.15 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 8.62 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.62 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Unichem Laboratories Ltd.

What is Unichem Lab share price?
Can I buy Unichem Lab shares now?
What is the Dividend Yield of Unichem Lab?
What is the Market Cap of Unichem Lab?
What are the key metrics to analyse Unichem Lab?
What is the 52 Week High and Low of Unichem Lab?
What is the trend of Unichem Lab share price?